Pages that link to "Q36162154"

The following pages link to Sexuality and schizophrenia: a review (Q36162154):

Displaying 39 items.

• Management of sexual dysfunction due to antipsychotic drug therapy (Q24197558) (← links)
• Side effects of atypical antipsychotics: a brief overview (Q24642721) (← links)
• Antipsychotic-induced hyperprolactinemia (Q28305237) (← links)
• Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks. (Q30370326) (← links)
• The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. (Q33619940) (← links)
• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (Q34623350) (← links)
• Sexual dysfunction in schizophrenia: focus on recent evidence (Q34761446) (← links)
• Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). (Q34966395) (← links)
• Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study (Q35029078) (← links)
• Quantifying clinical relevance in the treatment of schizophrenia (Q35819467) (← links)
• Aripiprazole: the evidence of its therapeutic impact in schizophrenia (Q35876413) (← links)
• Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial (Q36192428) (← links)
• The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders (Q36570221) (← links)
• Antipsychotic-induced sexual dysfunction and its management (Q36758151) (← links)
• Psychotropics and sexual dysfunction (Q37711569) (← links)
• Sexual side effects of pharmacological treatment of psychiatric diseases. (Q37776404) (← links)
• Clinical interventions for women with schizophrenia: pregnancy (Q38020196) (← links)
• Exploring sexual risks in a forensic mental health hospital: perspectives from patients and nurses. (Q40461824) (← links)
• Talking about sexuality with consumers of mental health services (Q43458210) (← links)
• Transformations of self and sexuality: psychologically modified experiences in the context of forensic mental health (Q43892808) (← links)
• Do therapeutic homework assignments address areas of need for individuals with severe mental illness? (Q44501936) (← links)
• The 5-As framework for including sexual concerns in mental health nursing practice (Q45243715) (← links)
• Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population (Q46118805) (← links)
• Opportunity lost? Psychiatric medications and problems with sexual function: a role for nurses in mental health. (Q46235015) (← links)
• Talking about sex as part of our role: making and sustaining practice change. (Q46680532) (← links)
• The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management (Q47553823) (← links)
• Supporting the Sexual Intimacy Needs of Patients in a Longer Stay Inpatient Forensic Setting (Q47694437) (← links)
• An exploration of sexual desire and sexual activities of women with psychosis (Q48069849) (← links)
• Sex Education Groups in a Psychiatric Day Hospital: Clinical Observations (Q50604794) (← links)
• Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes (Q50794596) (← links)
• Assessment of sexual dysfunction and associated factors among patients with schizophrenia in Ethiopia, 2017. (Q55264783) (← links)
• Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study (Q61446259) (← links)
• Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: A case series (Q83295147) (← links)
• Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats (Q84010902) (← links)
• Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens (Q88443372) (← links)
• Sexual Expression and It's Determinants, in People Diagnosed with Psychotic Disorders (Q88733309) (← links)
• Sexual health of women with schizophrenia: a review (Q91989564) (← links)
• The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling (Q93271352) (← links)
• Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia (Q95270792) (← links)